Skip to main content
. 2023 Sep 11;16:17562848231197923. doi: 10.1177/17562848231197923

Figure 1.

Figure 1.

Matching of patients.

*For patients in the biosimilar remainder cohort, the infliximab biosimilar administration date closest prior to the matching date was assigned as their index date.